Echovirus Diagnostics Market Overview
Echovirus Diagnostics Market size is estimated to reach $231.5 million by 2027, growing at a CAGR of 3.2% during the forecast period 2022-2027. The echovirus is one of the numerous kinds of viruses that reside in the digestive system, also termed the gastrointestinal (GI) tract. The name “echovirus” is derived from the enteric cytopathic human orphan (ECHO) virus. Echoviruses are associated with a class of viruses termed enteroviruses. The physician may utilize one or more of the laboratory tests like rectal culture, stool culture, throat culture, or spinal fluid culture to diagnose an echovirus infection. Under rectal culture, a swab of tissue from the rectum is tested for the existence of viral material. As part of stool culture, sample of the faeces is tested for the existence of the virus. A throat culture involves a swab of the throat being investigated to look for the virus in saliva or mucus. Spinal fluid culture is the test wherein cerebrospinal fluid (CSF) is fetched from the spine and investigated to look for viral material that may bring about meningitis.
The surging technological progress in molecular diagnostic techniques is set to drive the Echovirus Diagnostics Market. The expansion in government health programs, specifically in developing countries, and the execution of laboratory tests like rectal culture are set to propel the growth of the Echovirus Diagnostics Market during the forecast period 2022-2027. This represents the Echovirus Diagnostics Industry Outlook.
The report: “Echovirus Diagnostics Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Echovirus Diagnostics Market.
By Clinical Application: Molecular Diagnostics,
Immunoassays, Differential Light Scattering, Information Technology, Liposomes,
Flow Cytometry, Chromatography, Gel Micro-Droplets, Diagnostic Imaging,
Monoclonal Antibodies, Others.
By End-User: Hospitals, Commercial/Private Laboratories, Physician Offices, Public Health Laboratories.
By Geography: North America (U.S, Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), and Rest Of The World (Middle East, Africa).
- Geographically, North America Echovirus Diagnostics Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the existence of an abundant count of leading key players pertaining to echovirus diagnostics and the performance of laboratory tests like rectal culture in the North American region.
- Echovirus Diagnostics Market growth is being driven by the increasing predominance of echovirus contamination among all ages of people owing to its transmissible character involving carrying out laboratory tests like rectal culture. However, long-term care or further treatment may be required if a patient develops encephalitis or myocarditis from an echovirus infection involving physical therapy for movement loss or speech therapy for loss of communication skills and this is one of the major factors hampering the growth of Echovirus Diagnostics Market.
- Echovirus Diagnostics Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Echovirus Diagnostics Market report.
Echovirus Diagnostics Market: Market Share (%) by Region, 2021
For more details on this report - Request for Sample
Echovirus Diagnostics Market Segment Analysis – By Clinical Application:
The Echovirus Diagnostics Market based on the clinical application can be further segmented into Molecular Diagnostics, Immunoassays, Differential Light Scattering, Information Technology, Liposomes, Flow Cytometry, Chromatography, Gel Micro-Droplets, Diagnostic Imaging, Monoclonal Antibodies, and Others. The Molecular Diagnostics Segment held the largest market share in 2021. This growth is owing to the surging progress in molecular diagnostic technologies. Typical laboratory tests like rectal culture are utilized by physicians to diagnose echovirus infections. For the discovery of echovirus 30 in 50 patients with aseptic meningitis, the multiplex reverses transcription (RT)-PCR was more sensitive (90% sensitivity) than cell culture (26% sensitivity) and the Amplicor EV test (86% sensitivity). The soaring count f investigations on cases of echovirus infections involving molecular diagnostic techniques are further propelling the growth of the Molecular Diagnostics segment.
Furthermore, the Immunoassays segment is estimated to grow with the fastest CAGR of 4.5% during the forecast period 2022-2027 owing to the soaring innovations in immunoassays performed by key players like Serion Diagnostics involving SERION ELISA classic Echovirus IgA, IgG, and IgM tests which are qualitative and quantitative immunoassays for the display of human antibodies, in serum or plasma, aimed against ECHO viruses apart from the application of laboratory tests like rectal culture utilized by physicians to diagnose echovirus infections.
Echovirus Diagnostics Market Segment Analysis – By End-User
The Echovirus Diagnostics Market based on end-user can be further segmented into Hospitals, Commercial/Private Laboratories, Physician Offices, and Public Health Laboratories. The Hospitals segment held the largest market share in 2021. This growth is owing to the surging and effortless accessibility of the most-recent diagnostic techniques and equipment pertaining to echovirus infections in hospitals. The soaring availability of qualified physicians to treat echovirus infections utilizing laboratory tests like rectal culture to diagnose echovirus infections is further propelling the growth of this segment.
Furthermore, the Commercial/Private Laboratories segment is estimated to grow with the fastest CAGR of 4.9% during the forecast period 2022-2027 owing to the proliferating accessibility of equipment and trained laboratory personnel to perform laboratory tests like rectal culture utilized by physicians to diagnose echovirus infections, offering of quality health care and multi-specialty coverage.
Echovirus Diagnostics Market Segment Analysis – By Geography:
The Echovirus Diagnostics Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America and Rest of the World. North America (Echovirus Diagnostics Market) held the largest share with 35% of the overall market in 2021. The growth of this region is owing to the surging predominance of echovirus infections in the North American region. Typical laboratory tests utilized by physicians to diagnose echovirus infection include rectal culture, stool culture, throat culture, and spinal fluid culture. The soaring healthcare spending is further propelling the growth of the Echovirus Diagnostics Market in the North American region.
Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like the proliferating pervasiveness of echovirus infections and the enormous patient population in the Asia-Pacific region. The developing healthcare technology along with the application of laboratory tests like rectal culture by physicians to diagnose echovirus infections is further propelling the progress of the Echovirus Diagnostics Market in the Asia-Pacific region.
Echovirus Diagnostics Market Drivers
Surging Predominance Of Echovirus Infections Is Projected To Drive The Growth Of Echovirus Diagnostics Market:
The echovirus is one of the numerous kinds of viruses that reside in the digestive system, also termed the gastrointestinal (GI) tract. The term “echovirus” is derived from the enteric cytopathic human orphan (ECHO) virus. Echoviruses are associated with a class of viruses termed enteroviruses. They are second only to rhinoviruses as the most typical viruses that affect people. Rhinoviruses are frequently accountable for bringing about the common cold. As per the Centers for Disease Control and Prevention (CDC), there are approximately 10 to 15 million enterovirus infections in the U.S. every year that bring about distinct symptoms. One can become contaminated with an echovirus in numerous distinct ways, inclusive of:
- coming into contact with faeces infected by the virus
- breathing in contaminated airborne particles
- making physical contact with surfaces infected with the virus
The sickness that results from contamination by an echovirus is mostly gentle and should respond to treatment at home with over-the-counter medications and rest. However, in unique cases, contaminations and their symptoms can become serious and require medical treatment. Nearly all people contaminated by an echovirus do not have any symptoms. If symptoms do appear, they are mostly mild and influence the upper respiratory tract. Probable symptoms include viral meningitis. Certain laboratory tests utilized by physicians to diagnose an echovirus infection include rectal culture and stool culture. The surging predominance of echovirus infections is therefore fuelling the growth of the Echovirus Diagnostics Market during the forecast period 2022-2027.
Soaring Innovations In Echovirus Diagnostics Are Expected To Boost Market Growth:
Thirty-four echoviruses are recognized. Furthermore, “Human echoviruses 1–7, 9, 11–21, 24–27, and 29–33 are strains of the species Enterovirus B of the genus Enterovirus”. Apart from the application of laboratory tests like rectal culture by physicians, to diagnose echovirus infections, proliferating innovations are leading the way in Echovirus Diagnostics. Serion Diagnostics has developed the SERION ELISA classic Echovirus IgA, IgG, and IgM tests which are qualitative and quantitative immunoassays for the display of human antibodies, in serum or plasma, aimed against ECHO viruses. The differential detection of the distinct antibody classes assists the progress of the proof of contact with the organism and backs the classification of the ailment phase. Some of the focal points include the application of a blend of recombinant antigens derived from conserved and subtype-specific epitopes of the VP1 proteins of ECHO virus E6 and E9 and the display of all serotypes owing to the selected antigen. The soaring innovations in echovirus diagnostics are therefore driving the growth of the Echovirus Diagnostics Market during the forecast period 2022-2027.
Echovirus Diagnostics Market Challenges
Challenges Of Echovirus Diagnostics Are Hampering The Growth Of The Echovirus Diagnostics Market:
Nearly all newborns with life-alarming enterovirus (EV) ailment are contaminated by vertical transmission from the contaminated mother in the perinatal period. Around 60% to 70% of women who give birth to contaminated infants have febrile sickness during the last week of pregnancy. A 9-month-old boy lost his life owing to a disseminated echovirus 7 (E7) contamination with the virus being cultured from his liver and spleen. His hepatic failure was made complex by candidiasis and marrow hypoplasia and aggravated by a likely immune deficiency. There are numerous documented cases of echovirus 11 bringing about very severe sickness in infants and young children. Researchers are still working to comprehend these viruses. Nearly all echoviruses are spread by way of contact with fecal matter. Newborns can acquire the virus at the time of birth from their mothers. The virus may not bring about any symptoms in the digestive tract, however, it can bring about dangerous contamination in someone with a weakened or less-established immune system. Certain investigations have noted that there can be outbreaks of enteroviruses, inclusive of echovirus 11, in bigger communities. Outbreaks can also occur in tinier groups of children, like those who share a nursery or care facility. Nearly all cases of echovirus in mature grown-ups come from being exposed to contaminated children. These issues are thus hampering the growth of the Echovirus Diagnostics Market.
Echovirus Diagnostics Industry Outlook:
Innovative technologies and products, mergers and acquisitions, business expansion opportunities and alternative market penetration strategies are key strategies adopted by players in the Echovirus Diagnostics Market. Key companies of this market are:
- Abbott Laboratories, Inc.
- Gen-Probe, Inc.
- Danaher Corporation
- Becton Dickinson and Company
- Novartis Diagnostics
- F. Hoffmann-La Roche Ltd.
- Siemens Ltd.
- Ortho-Clinical Diagnostics
- Thermo Fisher Scientific, Inc.
- In October 2020, Beckman Coulter, whose parent company is Danaher Corporation, introduced its SARS-CoV-2 IgM antibody test in countries acquiring CE Mark and planned to commence shipping to diagnostics labs. The novel IgM antibody test displayed 99.9% specificity with 1,400 negative samples and 98.3% sensitivity at 15-30 days post-symptom outset. Beckman Coulter's IgM assay is the portion of a complete suite of testing solutions the firm is establishing to notify clinical and public health decision-making at the time of the COVID-19 pandemic.
- In July 2020, Danaher Corporation introduced completely integrated SCIEX OS Software a virtual product experience. Set up on usability, effectiveness, and integrity, SCIEX OS Software Powers Up the most recent innovations in mass spectrometry. SCIEX, a global leader in life science analytical technologies, launches the completely integrated SCIEX OS Software, the core engine operating SCIEX innovations.
- In April 2020, Abbott introduced its third test for coronavirus (COVID-19) and is shipping tests to hospitals across the U.S. The test is a serology test – also termed antibody test – which could be a crucial next step in combating this virus. Abbott's test assists to discover the IgG antibody to SARS-CoV-2.